Due to its role in driving translation elongation, the substrate of eEF2K, eEF2, is overexpressed in gastrointestinal malignancies, including CRC, and its knockdown impairs the proliferative potential of CRC cells [103,104]. Here, EEF2K is linked to colorectal carcinoma.